A Modified CGM Algorithm Enhances Data Availability While Retaining iCGM Performance [0.03%]
一种改良的CGM算法，在提高数据可用性的同时保持与iCGM性能一致
Rebecca A Harvey Towers,Xiaohe Zhang,Rasoul Yousefi et al.
Rebecca A Harvey Towers et al.
The algorithm for the Dexcom G6 CGM System was enhanced to retain accuracy while reducing the frequency and duration of sensor error. The new algorithm was evaluated by post-processing raw signals collected from G6 pivotal trials (NCT028802...
Two Decades of Research in Artificial Pancreas: Insights from a Bibliometric Analysis [0.03%]
人工胰腺二十年研究：文献计量分析见解
Fabian León-Vargas,Jineth Andrea Arango Oviedo,Héctor Javier Luna Wandurraga
Fabian León-Vargas
Background: Artificial pancreas is a well-known research topic devoted to achieving better glycemic outcomes that has been attracting increasing attention over the years. However, there is a lack of systematic, chronologi...
Association Between Management of Continuous Subcutaneous Basal Insulin Administration and HbA1C [0.03%]
基础胰岛素持续皮下输注的管理与HbA1C的关系分析
Harry Rubin-Falcone,Ian Fox,Emily Hirschfeld et al.
Harry Rubin-Falcone et al.
Background: While we expect that patients who adjust their insulin delivery algorithms between clinic visits to have better glucose control compared to those who do not, this effect has not been quantified. ...
Inpatient Insulin Pen Implementation, Waste, and Potential Cost Savings: A Community Hospital Experience [0.03%]
住院胰岛素笔的使用、浪费及潜在的成本节约：社区医院的经验
Urooj Najmi,Waqas Zia Haque,Umair Ansari et al.
Urooj Najmi et al.
Background: Insulin pen injectors ("pens") are intended to facilitate a patient's self-administration of insulin and can be used in hospitalized patients as a learning opportunity. Unnecessary or duplicate dispensation of...
Initiating Insulin in the Emergency Center and Urgent Care to Prevent Hospital Admission for Patients with Hyperglycemia: A Unique Insulin Starter Kit [0.03%]
在急诊中心和急症护理中启动胰岛素以防止高血糖患者的住院治疗：一种独特的胰岛素起始工具包
Janet L Davidson,Richard M Bergenstal,Jessica A Conry et al.
Janet L Davidson et al.
Background: Clinicians in the Emergency Center (EC) and Urgent Care (UC) can play a vital role in preventing hospital admissions and improving outcomes of patients with newly diagnosed diabetes or pre-existing diabetes wh...
Small Fiber Neuropathy in Diabetes Polyneuropathy: Is It Time to Change? [0.03%]
糖尿病多发性神经病变中的小纤维神经病：是否到了改变的时候？
Sanjeev Sharma,Prashanth Vas,Gerry Rayman
Sanjeev Sharma
Diabetes polyneuropathy is an important complication of diabetes polyneuropathy, and its notable sequelae of foot ulceration, autonomic dysfunction, and neuropathic pain are associated with significant morbidity and mortality. Despite the m...
Design and Development of a Mobile-Based Self-Care Application for Patients with Type 2 Diabetes [0.03%]
一种针对二型糖尿病患者的基于手机的自我护理应用的设计与开发
Esmaeil Mehraeen,Mohammad Mehrtak,Nazanin Janfaza et al.
Esmaeil Mehraeen et al.
Introduction: Mobile-based applications play a leading role in changes in life-style, improve medication adherence, and provide a unique opportunity to aid patients with type 2 diabetes mellitus (T2DM) elevate their healt...
Jennifer Y Zhang,Trisha Shang,Suneil K Koliwad et al.
Jennifer Y Zhang et al.
In this issue of JDST, Alva and colleagues present for the first time, development of a continuous ketone monitor (CKM) tested both in vitro and in humans. Their sensor measured betahydroxybutyrate (BHB) in interstitial fluid (ISF). The sen...
Feasibility of Continuous Ketone Monitoring in Subcutaneous Tissue Using a Ketone Sensor [0.03%]
用于皮下组织的酮体传感器连续监测可行性研究
Shridhara Alva,Kristin Castorino,Hyun Cho et al.
Shridhara Alva et al.
Background: The feasibility of measuring β-hydroxybutyrate in ISF using a continuous ketone monitoring (CKM) sensor using a single calibration without further adjustments over 14 days is described. ...
Safety and Feasibility Evaluation of Step Count Informed Meal Boluses in Type 1 Diabetes: A Pilot Study [0.03%]
基于步数的餐时胰岛素注射在1型糖尿病患者中安全性和可行性的评估：一项试点研究
Basak Ozaslan,Sue A Brown,Jennifer Pinnata et al.
Basak Ozaslan et al.
Background: Physical activity can cause glucose fluctuations both during and after it is performed, leading to hurdles in optimal insulin dosing in people with type 1 diabetes (T1D). We conducted a pilot clinical trial as...
Randomized Controlled Trial
Journal of diabetes science and technology. 2022 May;16(3):670-676. DOI:10.1177/1932296821997917 2022